INTERNATIONAL BIOTECHNOLOGY TRUST PLC
Portfolio update as at 30 June 2010
|
Total Net Assets |
£96.6m |
|
NAV per share |
160.0p |
|
Share Price |
141.5p |
|
Total value of unquoted investments |
£23.1m |
|
Total number of portfolio companies |
60 |
|
Cash |
3% |
|
Cash committed and reserved to unquoted investments |
14% |
|
Portfolio companies with < 1 year of cash |
7% |
Top Ten Holdings
|
Company Name |
% NAV |
|
Celgene |
5.77 |
|
Amgen |
5.67 |
|
Micromet |
5.39 |
|
Shire |
4.86 |
|
Alexion Pharmaceuticals |
4.06 |
|
Genzyme |
3.65 |
|
Gilead Sciences |
3.54 |
|
EV3 |
3.45 |
|
EUSA Pharma |
3.24 |
|
Oxagen |
3.01 |
|
|
----------- |
|
Total |
42.64 |
|
Geographical Allocation |
% |
|
United States |
75 |
|
Europe |
20 |
|
Cash |
3 |
|
Australia |
2 |
|
|
----------- |
|
Total |
100 |
|
Quoted/Unquoted allocation |
% |
|
Quoted |
73 |
|
Unquoted |
24 |
|
Cash |
3 |
|
|
----------- |
|
|
100 |
BNP Paribas Secretarial Services Limited
Company Secretary
19 JULY 2010